Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Firouzeh, Arjmandi"'
Publikováno v:
Journal of Breast Imaging. 2:524-529
The widespread acceptance of screening mammography for early detection, along with advances in treatment, have combined to decrease the overall mortality rate from breast cancer. However, significant disparities in health outcomes persist. Socioecono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1017dff0e74163232e9c8e8b3e22a2cd
https://doi.org/10.1093/jbi/wbaa093
https://doi.org/10.1093/jbi/wbaa093
Autor:
Firouzeh Arjmandi, Jessica H. Porembka, Dogan Polat, Basak E. Dogan, Venetia R. Sarode, Jennifer G. Schopp, Yin Xi, Deborah Farr
Publikováno v:
Breast Cancer Research and Treatment. 185:479-494
To investigate the performance of an imaging and biopsy parameters-based multivariate model in decreasing unnecessary surgeries for high-risk breast lesions. In an IRB-approved study, we retrospectively reviewed all high-risk lesions (HRL) identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6965b67e0dfcd499f0e4b29f25cbb432
https://doi.org/10.1007/s10549-020-05947-1
https://doi.org/10.1007/s10549-020-05947-1
Publikováno v:
Breast cancer research and treatment. 187(2)
Axillary nodal status is one of the most important prognostic factors in breast cancer. While sentinel lymph node biopsy (SLNB) is a safe and validated procedure for clinically node-negative patients, axillary management of clinically node-positive p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bfce6c7be7e79ac48a086debe1556d0
https://pubmed.ncbi.nlm.nih.gov/33982209
https://pubmed.ncbi.nlm.nih.gov/33982209
Autor:
Dogan S, Polat, Jennifer G, Schopp, Firouzeh, Arjmandi, Jessica, Porembka, Venetia, Sarode, Deborah, Farr, Yin, Xi, Basak E, Dogan
Publikováno v:
Breast cancer research and treatment. 185(2)
To investigate the performance of an imaging and biopsy parameters-based multivariate model in decreasing unnecessary surgeries for high-risk breast lesions.In an IRB-approved study, we retrospectively reviewed all high-risk lesions (HRL) identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7a2d249aa238d63fa5786e7484a2dc1
https://pubmed.ncbi.nlm.nih.gov/33010022
https://pubmed.ncbi.nlm.nih.gov/33010022